{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:31:45Z","timestamp":1792009905272,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,16]]},"DOI":"10.7759\/cureus.84258","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T05:51:03Z","timestamp":1747461063000},"source":"Crossref","is-referenced-by-count":2,"title":["Evaluating Hepatokines in the Progression of Non-alcoholic Fatty Acid Liver Disease by Decoding Liver-Derived Molecular Pathologies"],"prefix":"10.7759","author":[{"given":"Shehwar","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soobia","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulman","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Khaliq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhmmad Hussain","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2024.04.013","article-title":"Metabolic dysfunction-associated steatotic liver disease: evolution of the final terminology","volume":"124","author":"Portincasa P","year":"2024","unstructured":"Portincasa P, Baffy G. Metabolic dysfunction-associated steatotic liver disease: evolution of the final terminology. Eur J Intern Med. 2024, 124:35-9. 10.1016\/j.ejim.2024.04.013","journal-title":"Eur J Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.07.033","article-title":"Disease state transition probabilities across the spectrum of NAFLD: a systematic review and meta-analysis of paired biopsy or imaging studies","volume":"21","author":"Le P","year":"2023","unstructured":"Le P, Payne JY, Zhang L, et al.. Disease state transition probabilities across the spectrum of NAFLD: a systematic review and meta-analysis of paired biopsy or imaging studies. Clin Gastroenterol Hepatol. 2023, 21:1154-68. 10.1016\/j.cgh.2022.07.033","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02335-9","article-title":"Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation","volume":"61","author":"Miao X","year":"2024","unstructured":"Miao X, Alidadipour A, Saed V, et al.. Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation. Acta Diabetol. 2024, 61:1339-61. 10.1007\/s00592-024-02335-9","journal-title":"Acta Diabetol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1119005","article-title":"The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease","volume":"10","author":"Qin L","year":"2023","unstructured":"Qin L, Wu J, Sun X, Huang X, Huang W, Weng C, Cai J. The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease. Front Cardiovasc Med. 2023, 10:1119005. 10.3389\/fcvm.2023.1119005","journal-title":"Front Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjad073","article-title":"The interplay between the muscle and liver in the regulation of glucolipid metabolism","volume":"15","author":"Chen C","year":"2024","unstructured":"Chen C, Xie L, Zhang M, Shama, Cheng KK, Jia W. The interplay between the muscle and liver in the regulation of glucolipid metabolism. J Mol Cell Biol. 2024, 15:10.1093\/jmcb\/mjad073","journal-title":"J Mol Cell Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1566-9_4","article-title":"Assessing heterogeneity in random-effects meta-analysis","volume":"2345","author":"Langan D","year":"2022","unstructured":"Langan D. Assessing heterogeneity in random-effects meta-analysis. Methods Mol Biol. 2022, 2345:67-89. 10.1007\/978-1-0716-1566-9_4","journal-title":"Methods Mol Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-019-1172-8","article-title":"Risk of bias tools in systematic reviews of health interventions: an analysis of PROSPERO-registered protocols","volume":"8","author":"Farrah K","year":"2019","unstructured":"Farrah K, Young K, Tunis MC, Zhao L. Risk of bias tools in systematic reviews of health interventions: an analysis of PROSPERO-registered protocols. Syst Rev. 2019, 8:280. 10.1186\/s13643-019-1172-8","journal-title":"Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2025.109314","article-title":"GRADE guidance 40: the GRADE evidence-to-decision framework for environmental and occupational health","volume":"197","author":"Senerth E","year":"2025","unstructured":"Senerth E, Whaley P, Akl E, et al.. GRADE guidance 40: the GRADE evidence-to-decision framework for environmental and occupational health. Environ Int. 2025, 197:109314. 10.1016\/j.envint.2025.109314","journal-title":"Environ Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/nu13092928","article-title":"Independent dose-response associations between Fetuin-A and lean nonalcoholic fatty liver disease","volume":"13","author":"Lu CW","year":"2021","unstructured":"Lu CW, Lee YC, Chiang CH, Chang HH, Yang WS, Huang KC. Independent dose-response associations between Fetuin-A and lean nonalcoholic fatty liver disease. Nutrients. 2021, 13:10.3390\/nu13092928","journal-title":"Nutrients"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v15.i3.418","article-title":"Predictive value of angiopoietin-like protein 8 in metabolic dysfunction-associated fatty liver disease and its progression: a case-control study","volume":"15","author":"Gan LL","year":"2024","unstructured":"Gan LL, Xia C, Zhu X, et al.. Predictive value of angiopoietin-like protein 8 in metabolic dysfunction-associated fatty liver disease and its progression: a case-control study. World J Diabetes. 2024, 15:418-28. 10.4239\/wjd.v15.i3.418","journal-title":"World J Diabetes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12449\/JCH240409","article-title":"Value of Fetuin-A, Fetuin-B, and insulin resistance index in predicting nonalcoholic fatty liver disease","volume":"40","author":"Sulian YA","year":"2024","unstructured":"Sulian YA, Rongjie SH, Lihua LI. Value of Fetuin-A, Fetuin-B, and insulin resistance index in predicting nonalcoholic fatty liver disease. J Clin Hepatol. 2024, 40:694-9. 10.12449\/JCH240409","journal-title":"J Clin Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2020.0222","article-title":"Serum retinol-binding protein levels are associated with nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus: a real-world study","volume":"46","author":"Zhang ZH","year":"2022","unstructured":"Zhang ZH, Ke JF, Lu JX, Liu Y, Wang AP, Li LX. Serum retinol-binding protein levels are associated with nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus: a real-world study. Diabetes Metab J. 2022, 46:129-39. 10.4093\/dmj.2020.0222","journal-title":"Diabetes Metab J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14351","article-title":"Hepatokine leukocyte cell-derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction-associated steatotic liver disease in the general population","volume":"16","author":"Suzuki K","year":"2025","unstructured":"Suzuki K, Tsujiguchi H, Hara A, et al.. Hepatokine leukocyte cell-derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction-associated steatotic liver disease in the general population. J Diabetes Investig. 2025, 16:298-308. 10.1111\/jdi.14351","journal-title":"J Diabetes Investig"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10736-9","article-title":"Adipokine\/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study","volume":"19","author":"Yi X","year":"2025","unstructured":"Yi X, Han L, Li L, Zhu H, Li M, Gao S. Adipokine\/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study. Hepatol Int. 2025, 19:143-55. 10.1007\/s12072-024-10736-9","journal-title":"Hepatol Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15686","article-title":"Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients","volume":"43","author":"Franck M","year":"2023","unstructured":"Franck M, John K, Al Aoua S, et al.. Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients. Liver Int. 2023, 43:2668-79. 10.1111\/liv.15686","journal-title":"Liver Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-023-02767-w","article-title":"Relationship between the changes in hepatokine levels and metabolic effects after laparoscopic sleeve gastrectomy in severely obese patients","volume":"54","author":"Umemura A","year":"2024","unstructured":"Umemura A, Sasaki A, Takamura T, et al.. Relationship between the changes in hepatokine levels and metabolic effects after laparoscopic sleeve gastrectomy in severely obese patients. Surg Today. 2024, 54:581-90. 10.1007\/s00595-023-02767-w","journal-title":"Surg Today"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102693","article-title":"Effectiveness of the pomegranate extract in improving hepatokines and serum biomarkers of non-alcoholic fatty liver disease: A randomized double blind clinical trial","volume":"17","author":"Jafarirad S","year":"2023","unstructured":"Jafarirad S, Goodarzi R, Mohammadtaghvaei N, Dastoorpoor M, Alavinejad P. Effectiveness of the pomegranate extract in improving hepatokines and serum biomarkers of non-alcoholic fatty liver disease: A randomized double blind clinical trial. Diabetes Metab Syndr. 2023, 17:102693. 10.1016\/j.dsx.2022.102693","journal-title":"Diabetes Metab Syndr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073959","article-title":"Hepatic PTEN signaling regulates systemic metabolic homeostasis through hepatokines-mediated liver-to-peripheral organs crosstalk","volume":"23","author":"Berthou F","year":"2022","unstructured":"Berthou F, Sobolewski C, Abegg D, et al.. Hepatic PTEN signaling regulates systemic metabolic homeostasis through hepatokines-mediated liver-to-peripheral organs crosstalk. Int J Mol Sci. 2022, 23:10.3390\/ijms23073959","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan N","year":"2023","unstructured":"Stefan N, Schick F, Birkenfeld AL, H\u00e4ring HU, White MF. The role of hepatokines in NAFLD. Cell Metab. 2023, 35:236-52. 10.1016\/j.cmet.2023.01.006","journal-title":"Cell Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.258507","article-title":"Fetuin-A secretion from \u03b2-cells leads to accumulation of macrophages in islets, aggravates inflammation and impairs insulin secretion","volume":"134","author":"Mukhuty A","year":"2021","unstructured":"Mukhuty A, Fouzder C, Kundu R. Fetuin-A secretion from \u03b2-cells leads to accumulation of macrophages in islets, aggravates inflammation and impairs insulin secretion. J Cell Sci. 2021, 134:10.1242\/jcs.258507","journal-title":"J Cell Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137405","article-title":"Exploring fibrosis pathophysiology in lean and obese metabolic-associated fatty liver disease: an in-depth comparison","volume":"25","author":"Veskovi\u0107 M","year":"2024","unstructured":"Veskovi\u0107 M, Pejovi\u0107 M, \u0160utulovi\u0107 N, Hrn\u010di\u0107 D, Ra\u0161i\u0107-Markovi\u0107 A, Stanojlovi\u0107 O, Mladenovi\u0107 D. Exploring fibrosis pathophysiology in lean and obese metabolic-associated fatty liver disease: an in-depth comparison. Int J Mol Sci. 2024, 25:10.3390\/ijms25137405","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2024.100595","article-title":"ANGPTL8 deficiency attenuates lipopolysaccharide-induced liver injury by improving lipid metabolic dysregulation","volume":"65","author":"Feng Y","year":"2024","unstructured":"Feng Y, Luo S, Fang C, et al.. ANGPTL8 deficiency attenuates lipopolysaccharide-induced liver injury by improving lipid metabolic dysregulation. J Lipid Res. 2024, 65:100595. 10.1016\/j.jlr.2024.100595","journal-title":"J Lipid Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/ani12070939","article-title":"FGF21 reduces lipid accumulation in bovine hepatocytes by enhancing lipid oxidation and reducing lipogenesis via AMPK signaling","volume":"12","author":"Kong Y","year":"2022","unstructured":"Kong Y, Zhao C, Tan P, et al.. FGF21 reduces lipid accumulation in bovine hepatocytes by enhancing lipid oxidation and reducing lipogenesis via AMPK signaling. Animals (Basel). 2022, 12:10.3390\/ani12070939","journal-title":"Animals (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.967375","article-title":"The role of FGF21 and its analogs on liver associated diseases","volume":"9","author":"Falamarzi K","year":"2022","unstructured":"Falamarzi K, Malekpour M, Tafti MF, Azarpira N, Behboodi M, Zarei M. The role of FGF21 and its analogs on liver associated diseases. Front Med (Lausanne). 2022, 9:967375. 10.3389\/fmed.2022.967375","journal-title":"Front Med (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80689-0","article-title":"LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH","volume":"11","author":"Takata N","year":"2021","unstructured":"Takata N, Ishii KA, Takayama H, et al.. LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH. Sci Rep. 2021, 11:555. 10.1038\/s41598-020-80689-0","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5409\/wjcp.v13.i3.94721","article-title":"Selenoprotein-p and insulin resistance in children and adolescents with obesity","volume":"13","author":"Elbarky A","year":"2024","unstructured":"Elbarky A, Ismail KG, Yousef YF, Elshafiey RM, Elsharaby RM, El-Kaffas A, Al-Beltagi M. Selenoprotein-p and insulin resistance in children and adolescents with obesity. World J Clin Pediatr. 2024, 13:94721. 10.5409\/wjcp.v13.i3.94721","journal-title":"World J Clin Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-022-01771-2","article-title":"The relationship between NAFLD and retinol-binding protein 4 - an updated systematic review and meta-analysis","volume":"22","author":"Hu R","year":"2023","unstructured":"Hu R, Yang X, He X, Song G. The relationship between NAFLD and retinol-binding protein 4 - an updated systematic review and meta-analysis. Lipids Health Dis. 2023, 22:8. 10.1186\/s12944-022-01771-2","journal-title":"Lipids Health Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1254014","article-title":"Advance of serum biomarkers and combined diagnostic panels in nonalcoholic fatty liver disease","volume":"2022","author":"Zeng Y","year":"2022","unstructured":"Zeng Y, He H, An Z. Advance of serum biomarkers and combined diagnostic panels in nonalcoholic fatty liver disease. Dis Markers. 2022, 2022:1254014. 10.1155\/2022\/1254014","journal-title":"Dis Markers"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369078-evaluating-hepatokines-in-the-progression-of-non-alcoholic-fatty-acid-liver-disease-by-decoding-liver-derived-molecular-pathologies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T05:51:06Z","timestamp":1747461066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369078-evaluating-hepatokines-in-the-progression-of-non-alcoholic-fatty-acid-liver-disease-by-decoding-liver-derived-molecular-pathologies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.84258","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}